This inventor holds 1 USPTO granted patent. Top assignee: Novavax, Inc.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Mark A Chambers - Innovator in Mycobacterial Vaccine Development
Introduction
Mark A Chambers is a notable inventor based in London, GB. He has made significant contributions to the field of immunology, particularly in the development of vaccines against mycobacterial infections. His innovative work has the potential to enhance the immunity of subjects and provide effective vaccination methods.
Latest Patents
Mark A Chambers holds a patent for a mycobacterial vaccine. This patent, which is focused on compositions and methods for enhancing immunity against mycobacterial infections, includes formalin inactivated cultures of mycobacterium and a Novasome® adjuvant. The invention outlines methods for utilizing these compositions to improve vaccination outcomes.
Career Highlights
Chambers is currently associated with Novavax, Inc., a company known for its cutting-edge vaccine development. His work at Novavax has positioned him as a key player in the field of vaccine research and development. With a focus on innovative solutions, he continues to contribute to advancements in immunology.
Collaborations
Some of his notable coworkers include D Craig Wright and Joan Brisker. Their collaborative efforts in research and development have furthered the progress of vaccine technology.
Conclusion
Mark A Chambers is a distinguished inventor whose work in mycobacterial vaccine development showcases his commitment to enhancing public health through innovative solutions. His contributions are vital in the ongoing fight against infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile